Finance

Lists
DHC:NASDAQ
Diversified Healthcare Trust
$7.22
-0.89%
(-0.065) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DHC...
Open
$7.32
High
$7.33
Low
$7.07
Mkt. cap
1.75B
Avg. vol.
1.87M
Volume
1.28M
Dividend
0.55%
Quarterly dividend
$0.01
Ex-dividend date
Oct 19, 2026
52-wk high
$9.66
52-wk low
$4.34
EPS
-$0.63
Beta
2.35
Shares outstanding
242.53M
No. of employees
0
Open
$7.32
High
$7.33
Low
$7.07
Mkt. cap
1.75B
Avg. vol.
1.87M
Volume
1.28M
Dividend
0.55%
Quarterly dividend
$0.01
Ex-dividend date
Oct 19, 2026
52-wk high
$9.66
52-wk low
$4.34
EPS
-$0.63
Beta
2.35
Shares outstanding
242.53M
No. of employees
0
News stories
From web sources and news partners
About Diversified Healthcare Trust
CEO-
Employees0
Founded1998
HeadquartersNewton, Massachusetts, United States
SectorReal Estate
IndustryReal estate investment trust
Websitedhcreit.com
Analyst ratings
Based on 3 analysts giving stock ratings to DHC in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DHC in the last 3 months.
Highest
Current $7.22
$10.50 (+45.33%)
Average
$9.50 (+31.49%)
Lowest
$8.00 (+10.73%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Diana
Maxim Group
Buy
Reiterated
$10.50
+45.3%
11/04/2026
Zhiger Kurmet
Freedom Capital Markets
Buy
Maintained
$10.00
+38.4%
11/03/2026
Michael Carroll
RBC Capital
Hold
Maintained
$8.00
+10.7%
08/21/2026
John Massocca
B. Riley Securities
Buy
Reiterated
$11.00
+52.2%
06/09/2026
Last report
Nov 3, 2026
Fiscal period
Q3 2026
-$0.13 / -$0.13
-1.38%miss
Revenue / Est. (USD)
367.67M / 368.69M
-0.28%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
379.57M
366.47M
365.39M
367.67M
Cost of goods sold
316.15M
294.25M
284.03M
290.21M
Cost of revenue
316.15M
294.25M
284.03M
290.21M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.54M
14.04M
19.33M
14.64M
Operating expense
74.54M
76.95M
81.88M
77.50M
Total operating expenses
390.69M
371.20M
365.90M
367.71M
Operating income
-11.12M
-4.73M
-518.00K
-42.00K
Other non operating income
-
-
-
-
EBT including unusual items
-20.71M
-42.65M
-36.12M
-49.50M
EBT excluding unusual items
-29.33M
-41.45M
-35.49M
-34.07M
Income tax expense
514.00K
622.00K
1.30M
724.00K
Effective tax rate
-2.48%
-1.46%
-3.59%
-1.46%
Other operating expenses
-
-
-
-
Net income
-21.22M
-43.28M
-37.42M
-50.23M
Net profit margin
-5.59%
-11.81%
-10.24%
-13.66%
Earnings per share
-0.06
-0.13
-0.10
-0.13
Interest and investment income
1.53M
233.00K
258.00K
431.00K
Interest expense
-46.86M
-37.04M
-37.08M
-37.16M
Net interest expenses
-45.32M
-36.81M
-36.82M
-36.73M
Depreciation and amortization charges
62.01M
62.91M
62.54M
62.86M
EBITDA
50.92M
58.21M
62.05M
62.82M
Gain or loss from assets sale
-13.76M
1.21M
629.00K
893.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps